Risk of Incident Atherosclerotic Cardiovascular DiseaseEvents by Achieved Atherogenic Lipid Levels Among62,428 Statin-Treated Individuals With Diabetes Mellitus-Reference-Cited by-同舟云学术

Risk of Incident Atherosclerotic Cardiovascular DiseaseEvents by Achieved Atherogenic Lipid Levels Among62,428 Statin-Treated Individuals With Diabetes Mellitus

Published:2018-09 Issue:5 Volume:122 Page:762-767
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Rana Jamal S.,Liu Jennifer Y.^ORCID,Moffet Howard H.^ORCID,Boklage Susan H.,Khan Irfan,Karter Andrew J.

Funder

Kaiser Permanente

Regeneron Pharmaceuticals

Sanofi

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. National Diabetes Statistics Report A,2017

2. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies;Sarwar;Lancet,2010

3. 2013ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Stone;J Am Coll Cardiol,2014

4. An evidence-based guide to cholesterol-lowering guidelines;Waters;Can J Cardiol,2017

5. Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials;Boekholdt;J Am Coll Cardiol,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-HDL cholesterol and residual cardiovascular risk in statin-treated patients with and without diabetes: the Western Denmark Heart Registry;European Journal of Preventive Cardiology;2024-03-21

2. Consenso latinoamericano para el manejo del riesgo residual cardiometabólico. Consenso realizado por la Academia Latinoamericana de Lipidología y Riesgo Cardiometabólico (ALALIP), con el aval de la Sociedad Interamericana de Cardiología (SIAC), la Sociedad Interamericana de Aterosclerosis (IAS) y el Colegio Panamericano de Endotelio (PACE);Archivos de Cardiología de México;2021-11-23

3. Risk of Cardiovascular Events in Patients With Type 2 Diabetes and Metabolic Dyslipidemia Without Prevalent Atherosclerotic Cardiovascular Disease;The American Journal of Medicine;2020-02

4. Cholesterol levels and development of cardiovascular disease in Koreans with type 2 diabetes mellitus and without pre-existing cardiovascular disease;Cardiovascular Diabetology;2019-10-22

5. Evidence for changing lipid management strategy to focus on non-high density lipoprotein cholesterol;Lipids in Health and Disease;2019-06-07